While we only addressed the impact of MSX-3 on anxiety in our study behavior, which appears not affected by the antagonist, it will be important, in the future and from a therapeutic perspective, to evaluate more closely the impact of long-term A2AR blockade on AD-related behavioral symptoms. Here, ADORA2A is linked to Anxiety.